Previous Article | Next Article 
Journal of Clinical Microbiology, August 1998, p. 2294-2297, Vol. 36, No. 8
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection and Differentiation of vanC-1,
vanC-2, and vanC-3 Glycopeptide Resistance Genes
in Enterococci
Nancye C.
Clark,1,*
Lucia M.
Teixeira,2,3
Richard R.
Facklam,2 and
Fred C.
Tenover1
Hospital Infections
Program1 and
Division of Bacterial and
Mycotic Diseases,2 National Center for
Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia 30333, and
Instituto de Microbiologia,
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
219413
Received 9 February 1998/Returned for modification 16 March
1998/Accepted 12 May 1998
 |
ABSTRACT |
The VanC phenotype, as found in Enterococcus
gallinarum, E. casseliflavus, and E. flavescens, is characterized by intrinsic low-level resistance to
vancomycin. The nucleotide sequences of the vanC-1 gene in
E. gallinarum, the vanC-2 gene in
E. casseliflavus, and the vanC-3 gene in
E. flavescens have been reported, although there is
some disagreement as to whether E. flavescens is a
legitimate enterococcal species. Previous attempts to
differentiate the vanC-2 and vanC-3 genes by
PCR analysis have been unsuccessful. The purpose of the present study
was to detect and differentiate the three vanC determinants
and examine the distribution of these genes in a collection of both
typical and atypical enterococci. The 796-bp vanC-1 PCR
product was amplified only from E. gallinarum isolates. As expected, due to the extensive homology in the
vanC-2 and vanC-3 gene sequences, all of
the E. casseliflavus and E. casseliflavus/flavescens isolates produced the 484-bp
vanC-2 PCR product, although the E. gallinarum isolates were negative. Only the E. casseliflavus/flavescens isolates produced the 224-bp
vanC-3 product. Using the three sets of primers, we were
able to detect and distinguish the vanC-1,
vanC-2, and vanC-3 genes from both typical and
atypical enterococci strains. Antimicrobial susceptibility tests and
analysis of genomic DNA by pulsed-field gel electrophoresis were also
performed, but the results indicated that they were not able to
distinguish among strains possessing the three vanC genotypes.
 |
INTRODUCTION |
The VanC phenotype, as found in
Enterococcus gallinarum, E. casseliflavus,
and E. flavescens, is characterized by intrinsic low-level resistance to vancomycin. The nucleotide sequences of the
vanC-1 gene in E. gallinarum, the
vanC-2 gene in E. casseliflavus, and the
vanC-3 gene in E. flavescens have been
reported, although there is some disagreement as to whether
E. flavescens is a legitimate enterococcal species
(3, 7, 10, 18). Descheemaeker et al. were unable to
discriminate between E. casseliflavus and E. flavescens using pulsed-field gel electrophoresis (PFGE) or
oligonucleotide D11344-primed PCR (3). Previous attempts to
differentiate the vanC-2 and vanC-3 genes by PCR
analysis have also been unsuccessful (4, 11). Although these
organisms are not as clinically significant as the other members of the
group II enterococci, i.e., E. faecalis and
E. faecium, clusters of infection have previously been
reported (5, 6). In 1991, Pompei et al. reported four
strains of yellow-pigmented enterococci resembling E. casseliflavus, all of which were isolated from surgical patients
(13). These four strains were further characterized by
DNA-DNA hybridization and biochemical tests, and the differences were
considered significant enough for the strains to be designated a new
species, E. flavescens, with the type strain CCM 439 (12). E. casseliflavus was incriminated in a
series of bloodstream infections in a hemodialysis unit over an 8-month
period (9). Pigment production and the motility test can
usually differentiate E. faecium from the three
enterococcal species carrying vanC genes, while acid
production from ribose is the only biochemical test capable of
differentiating E. casseliflavus and E. flavescens. The variable nature of these characteristics, however,
complicates the proper identification of these species necessary for
epidemiologic studies (5, 6). The recent report of
vanC-1-containing E. faecalis and
E. faecium isolates also emphasizes the importance of
differentiation of the vanC genes for epidemiologic studies
(11).
The purposes of this study were (i) to detect and differentiate the
vanC genotypes, if possible, and (ii) to study the
distribution of the respective vanC genes among a collection
of typical and atypical enterococcal strains.
 |
MATERIALS AND METHODS |
Bacterial isolates.
The 30 isolates of enterococci with the
VanC phenotype characterized in this study, including 21 E. casseliflavus or E. casseliflavus-E. flavescens isolates and 9 E. gallinarum isolates,
are listed in Table 1. All of the
enterococcal isolates were identified at the Centers for Disease
Control and Prevention by standard methods (5, 6, 19). The
control strains included E. faecalis A256 (vanA genotype [16]), V583 (vanB
genotype [14]), and ATCC 19433 (type strain);
E. faecium ATCC 19434 (type strain), and E. gallinarum VR-42 (vanC-1 genotype
[2]). E. gallinarum SS-1228 (ATCC
49573 [type strain]) (vanC-1 genotype), E. casseliflavus SS-1229 (ATCC 25788 [type strain])
(vanC-2 genotype [10]), and E. flavescens SS-1317 (CCM-439 [type strain]) (vanC-3
genotype [10]) strains were included in the study.
E. flavescens SS-1317 (CCM-439), SS-1318 (CCM-440), and
SS-1319 (CCM-441) were received from Raffaello Pompei, Rome, Italy
(12, 13).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Characteristics, antimicrobial susceptibility, and
vanC PCR results of typical and atypical
Enterococcus species of
VanC phenotypea
|
|
Antimicrobial susceptibility testing.
All isolates were
tested by the broth microdilution method as described by the
National Committee for Clinical Laboratory Standards
(8) with cation-adjusted Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.). The antimicrobial agents tested were
ampicillin, ciprofloxacin, gentamicin, penicillin, rifampin, streptomycin, teicoplanin, and vancomycin. E. faecalis ATCC 29212 was the quality control strain used in
the susceptibility testing.
PCR amplification of antimicrobial resistance genes.
The
vanC genes that encode intrinsic low-level glycopeptide
resistance in the enterococci were amplified by PCR with
oligonucleotide primers selected from published sequences (4, 7,
10) with the assistance of the OLIGO software (National
Biosciences, Hamel, Maine). The PCR reaction mix and conditions for
amplification of the 796-bp vanC-1 gene product of
E. gallinarum (2) and the 484-bp
vanC-2 product of E. casseliflavus
(15) have been described previously. The primers used for
detection of the above genes were (5'
3') (+) GAA AGA CAA CAG GAA GAC
CGC and (
) ATC GCA TCA CAA GCA CCA ATC for vanC-1
(2) and (+) CGG GGA AGA TGG CAG TAT and (
) CGC AGG GAC GGT
GAT TTT for vanC-2 (15).
The novel primers selected for amplification of the 224-bp
vanC-3 gene product of E. flavescens were
(5'
3') (+) GCC TTT ACT TAT TGT TCC and (
) GCT TGT TCT TTG ACC TTA.
For amplification of the vanC-3 gene, two to three bacterial
colonies were suspended in 100 µl of sterile deionized water, and 2 µl of the suspension was added to the reaction mix containing 1× PCR
buffer II, 2.5 mM MgCl2, 0.2 mM deoxynucleoside
triphosphates (dATP, dCTP, dTTP, and dGTP), 0.5 µM each primer, and
2.5 U of native Taq DNA polymerase (PE Applied Biosystems,
Foster City, Calif.). A Perkin-Elmer Cetus 9600 DNA thermocycler was
programmed as described previously (2, 15).
Analysis of genomic DNA restriction patterns by PFGE.
The isolates were grown in Trypticase soy broth (BBL Microbiology
Systems, Cockeysville, Md.) overnight at 37°C with shaking. A
modification of the procedure described by Smith and Cantor (17) was used for preparation of the agarose plugs. Briefly, the pellet from 300 µl of broth was resuspended in 300 µl of TE buffer (10 mM Tris, 0.1 mM EDTA [pH 8.0]), mixed with an equal volume
of 1.8% agarose (65 to 68°C; Bio-Rad Chromosomal Grade Agarose;
Bio-Rad Chemical Co., Hercules, Calif.) in TE buffer, and poured into a
plug mold. Mutanolysin (20 U/ml), instead of lysozyme, and 1 to 2 µg
of RNase per ml was added to the EC lysis buffer (6 mM Tris [pH 7.5],
1 M NaCl, 100 mM EDTA [pH 7.5], 0.5% Brij-58, 0.2% sodium
deoxycholate, 0.5% Sarkosyl) used for treatment of the plugs overnight
at 37°C. This solution was replaced by ESP solution (0.5 M EDTA [pH
8.0], 1% Sarkosyl, and 1 mg of proteinase K per ml), and the plugs
were incubated overnight at 50°C with gentle shaking. The plugs were
washed with TE buffer and then stored at 4°C in TE buffer until
needed. After digestion with 20 U of SmaI (New England
BioLabs, Bedford, Maine), the plugs were placed in the wells of a 1%
FastLane agarose (FMC BioProducts, Bedford, Maine) in 0.5× TBE and
were electrophoresed at 200 V with a 0.1-s
20-s pulse time for
20 h at 14°C in the Bio-Rad CHEF-DRII system. The gels were
stained with ethidium bromide, the restricted DNA was visualized with
UV light, and the images were photographed with Polaroid type 55 film
(Polaroid Corporation, Cambridge, Mass.) or were saved with the Foto
Analyst Archiver System (Fotodyne, Inc., Hartland, Wis.) to floppy
disks. The data were analyzed, and a dendrogram was generated with the
Advanced Quantifier 1-D Match version 2.1 for Windows software
(BioImage, Ann Arbor, Mich.).
 |
RESULTS AND DISCUSSION |
The goal of this study was to detect and differentiate the three
vanC determinants and to examine the distribution of these genes in a collection of both typical and atypical enterococci. The
biochemical characteristics and identification results of the typical
and atypical VanC enterococci are given in Table 1. Although members of
the group II enterococci with VanC phenotypes normally are arginine
positive, motile, pigmented (except for E. gallinarum),
and ribose positive (except for E. flavescens), the
collection of strains selected for the present study included strains
with variable results in these reactions that would, in most cases,
prevent their proper identification. Precise identification of such
strains was previously obtained by using analysis of whole-cell protein
profiles and DNA-DNA reassociation experiments (18, 19).
Phenotypically, E. gallinarum is distinguished
from the E. faecium, E. casseliflavus, and E. flavescens strains by its
motility and lack of pigmentation (5, 6). However, three of
the E. gallinarum strains included in our study were
nonmotile, and two E. casseliflavus strains were
nonmotile and nonpigmented. On the other hand, E. flavescens has been differentiated from E. casseliflavus by its lack of acid production from ribose. Five of
the E. casseliflavus-E. flavescens isolates
included in the present study were negative for acid production from
ribose after conventional incubation for 7 days, suggesting that they
were E. flavescens. When the period of incubation was
extended to 1 month, all were positive for acid production from
ribose, thus eliminating the only phenotypic species distinction.
Atypical isolates, such as strains 1673-93 and 1703-93, as well as
616-93, 2628-95, and 2629-95, would appear to be E. faecium by conventional tests, because they are nonmotile and
nonpigmented, but PCR with the F1 and F2 primers as described by
Dutka-Malen et al. (4) failed to amplify the 550-bp
ddlE. faecium gene product in strains
1673-93 and 1703-93, suggesting that they are not E. faecium. Such strains would not be adequately identified on the
basis of phenotypic characteristics alone but could be identified only
by additional tests such as acidification of
methyl-
-D-glucopyranoside (MGP) and susceptibility to
efrotomycin as recently proposed (1).
The 796-bp vanC-1 PCR product was amplified only from the
E. gallinarum isolates and not from the E. casseliflavus or E. casseliflavus-E. flavescens isolates (Table 1 and Fig.
1A). As expected, due to the extensive
homology (98.3%) shared in the vanC-2 and vanC-3 gene sequences, all of the E. casseliflavus or
E. casseliflavus-E. flavescens isolates produced
the 484-bp vanC-2 PCR product; all E. gallinarum isolates were negative (Table 1 and Fig. 1A). Only the
E. casseliflavus-E. flavescens isolates produced
the 224-bp vanC-3 product (Table 1 and Fig. 1B). Organisms
yielding a vanC-1 gene product were reported as
E. gallinarum, those yielding the vanC-2
product only were reported as E. casseliflavus, and
those yielding both the vanC-2 and the
vanC-3 products were reported as E. casseliflavus-E. flavescens.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
Amplification of the vanC-1,
vanC-2, and vanC-3 enterococcal genes by PCR. The
standard in lane 1 is the 100-bp DNA ladder (Gibco/BRL, Gaithersburg,
Md.). (A) vanC-1 (796-bp) and vanC-2 (484-bp)
products amplified from selected study and control isolates with
vanC-1 and vanC-2 primers in the reaction mix.
Lanes 2 to 7 contain E. casseliflavus and E. casseliflavus-E. flavescens strains, and A256 and V583 are
E. faecalis strains. (B) The vanC-3 (224-bp)
products amplified from E. casseliflavus-E.
flavescens strains are seen in lanes 4 to 6.
|
|
We also varied the concentrations of the primers in our multiplex PCR
mixture containing the vanC-1 (0.1 µM), vanC-2
(0.1 µM), and vanC-3 (0.2 µM) primers in an attempt to
eliminate the production of the vanC-2 product by the
vanC-3-containing isolates (Fig.
2). We were not successful in eliminating
the product, but only the vanC-3 isolates produced both the
484-bp (vanC-2) and the 224-bp (vanC-3) products.
In the multiplex PCR, a 525-bp product was also amplified with both the
vanC-2 and vanC-3 genes resulting from the
combination of the vanC2(+) and vanC3(
)
primers. The 525-bp product appeared to predominate in isolates with
the vanC-3 gene, while the 484-bp product predominated with
the vanC-2 gene. Only the E. gallinarum
(vanC-1) isolate produced the expected 796-bp product.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Multiplex PCR of the vanC genes of
enterococcal strains with the VanC phenotype. The reaction mix
contained the vanC-1, vanC-2, and
vanC-3 primers for amplification of the respective genes.
Lanes 1 to 6, E. casseliflavus and E. casseliflavus-E. flavescens isolates; lanes 3 to 5, the
224-bp vanC-3 product specific for E. casseliflavus-E. flavescens isolates. Also, the 525-bp
product that appears to be more prominent in E. casseliflavus-E. flavescens isolates is seen. The 796-bp
vanC-1 gene product amplified in E. gallinarum strains is in lanes 10 and 12. The molecular size
standard is the 100-bp DNA ladder (Gibco/BRL Life Technologies,
Inc.).
|
|
The MICs for the VanC study isolates ranged from 2 to 8 µg/ml for
vancomycin; most E. gallinarum isolates were
intermediate (8 µg/ml), and all were susceptible to teicoplanin and
did not show high-level resistance to gentamicin or streptomycin (Table 1). None of the antimicrobials tested distinguished among the species.
As seen in the dendrogram (Fig. 3), PFGE
was not useful for differentiating the E. casseliflavus
and E. flavescens isolates. In all E. gallinarum strains except for SS-1228 (ATCC 49573 [type strain])
and 616-93, only smaller molecular fragments were seen (<150 kb) in
the PFGE patterns.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Dendrogram derived from analysis of the PFGE patterns of
SmaI-digested genomic DNA of enterococcal strains with the
VanC phenotype. E. casseliflavus-E. flavescens
strains are labeled E. flavescens in the figure because
of space limitations.
|
|
Antimicrobial susceptibility testing and PFGE were not able to
distinguish among strains possessing the three vanC gene
genotypes. In contrast, the use of the three sets of PCR primers
allowed us to detect and differentiate the vanC-1
(E. gallinarum), vanC-2 (E. casseliflavus), and vanC-3 (E. casseliflavus-E. flavescens) genes from typical and atypical
enterococcal strains. In all of the isolates characterized as
E. gallinarum, the 796-bp vanC-1 gene
product was amplified. Of the 21 E. casseliflavus or
E. casseliflavus-E. flavescens isolates, all were
shown to carry the vanC-2 gene, and 10 of them also
possessed the vanC-3 gene. Therefore, the presence of the
vanC genes may indicate a marker of species identification, and their detection may be an adjunct tool to assist in the precise identification of atypical strains. In a recent investigation testing
some of the strains included in the present study, E. casseliflavus and E. flavescens were found to be a
single species, and the term E. casseliflavus was
recommended to be retained as the species denomination (18,
19). Taking this into account and considering our results, the
presence of vanC-3 genes in some of the E. casseliflavus strains indicates that strains possessing the
vanC-3 gene may constitute genotypic variants of this
species. According to our data, such variants seem to be more
frequently associated with ribose-negative variants, including those
with a delayed reaction, of E. casseliflavus, which
were denominated E. casseliflavus-E. flavescens,
since the scope of the present study would not allow us to speculate on
the validity of the designation E. flavescens as a
separate species.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop G-08,
Atlanta, GA 30333. Phone: (404) 639-0195. Fax: (404) 639-1381. E-mail: ncc1{at}cdc.gov.
 |
REFERENCES |
| 1.
|
Carvalho, M. D. G. S.,
L. M. Teixeira, and R. R. Facklam.
1998.
Use of tests for acidification of methyl- -D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera.
J. Clin. Microbiol.
36:1584-1587[Abstract/Free Full Text].
|
| 2.
|
Clark, N. C.,
R. C. Cooksey,
B. C. Hill,
J. M. Swenson, and F. C. Tenover.
1993.
Characterization of glycopeptide-resistant enterococci from U.S. hospitals.
Antimicrob. Agents Chemother.
37:2311-2317[Abstract/Free Full Text].
|
| 3.
|
Descheemaeker, P.,
C. Lammens,
B. Pot,
P. Vandamme, and H. Goossens.
1997.
Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine.
Int. J. Syst. Bacteriol.
47:555-561[Abstract/Free Full Text].
|
| 4.
|
Dutka-Malen, S.,
S. Evers, and P. Courvalin.
1995.
Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
J. Clin. Microbiol.
33:24-27[Abstract]. (Erratum, 33:1434.)
|
| 5.
|
Facklam, R. R., and M. D. Collins.
1989.
Identification of Enterococcus species isolated from human infections by a conventional test scheme.
J. Clin. Microbiol.
27:731-734[Abstract/Free Full Text].
|
| 6.
|
Facklam, R. R., and D. F. Sahm.
1995.
Enterococcus, p. 308-314.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 7.
|
Leclercq, R.,
S. Dutka-Malen,
J. Duval, and P. Courvalin.
1992.
Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.
Antimicrob. Agents Chemother.
36:2005-2008[Abstract/Free Full Text].
|
| 8.
|
National Committee for Clinical Laboratory Standards.
1997.
Approved standard M7-A4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 9.
|
Nauschuetz, W. F.,
S. B. Trevino,
L. S. Harrison,
R. N. Longfield,
L. Fletcher, and W. G. Wortham.
1993.
Enterococcus casseliflavus as an agent of nosocomial bloodstream infections.
Med. Microbiol. Lett.
2:102-108.
|
| 10.
|
Navarro, F., and P. Courvalin.
1994.
Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.
Antimicrob. Agents Chemother.
38:1788-1793[Abstract/Free Full Text].
|
| 11.
|
Patel, R.,
J. R. Uhl,
P. Kohner,
M. K. Hopkins, and F. R. Cockerill, III.
1997.
Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
J. Clin. Microbiol.
35:703-707[Abstract].
|
| 12.
|
Pompei, R.,
F. Berlutti,
M. C. Thaller,
A. Ingianni,
G. Cortis, and B. Dainelli.
1992.
Enterococcus flavescens sp. nov., a new species of enterococci of clinical origin.
Int. J. Syst. Bacteriol.
42:365-369[Abstract/Free Full Text].
|
| 13.
|
Pompei, R.,
G. Lampis,
F. Berlutti, and M. C. Thaller.
1991.
Characterization of yellow-pigmented enterococci from severe human infections.
J. Clin. Microbiol.
29:2884-2886[Abstract/Free Full Text].
|
| 14.
|
Sahm, D. F.,
J. Kissinger,
M. S. Gilmore,
P. R. Murray,
R. Mulder,
J. Solliday, and B. Clarke.
1989.
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Antimicrob. Agents Chemother.
33:1588-1591[Abstract/Free Full Text].
|
| 15.
|
Satake, S.,
N. Clark,
D. Rimland,
F. S. Nolte, and F. C. Tenover.
1997.
Detection of vancomycin-resistant enterococci in fecal samples by PCR.
J. Clin. Microbiol.
35:2325-2330[Abstract].
|
| 16.
|
Shlaes, D. M.,
A. Bouvet,
C. Devine,
J. H. Shlaes,
S. Al-Obeid, and R. Williamson.
1989.
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.
Antimicrob. Agents Chemother.
33:198-203[Abstract/Free Full Text].
|
| 17.
|
Smith, C. L., and C. R. Cantor.
1987.
Purification, specific fragmentation, and separation of large DNA molecules.
Methods Enzymol.
155:449-467[Medline].
|
| 18.
|
Teixeira, L. M.,
M. G. S. Carvalho,
V. L. C. Merquior,
A. G. Steigerwalt,
M. G. M. Teixeira,
D. J. Brenner, and R. R. Facklam.
1997.
Recent approaches on the taxonomy of the enterococci and some related microorganisms.
Adv. Exp. Med. Biol.
418:397-400[Medline].
|
| 19.
| Teixeira, L. M., et al. Unpublished data.
|
Journal of Clinical Microbiology, August 1998, p. 2294-2297, Vol. 36, No. 8
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Naser, S. M., Vancanneyt, M., Hoste, B., Snauwaert, C., Vandemeulebroecke, K., Swings, J.
(2006). Reclassification of Enterococcus flavescens Pompei et al. 1992 as a later synonym of Enterococcus casseliflavus (ex Vaughan et al. 1979) Collins et al. 1984 and Enterococcus saccharominimus Vancanneyt et al. 2004 as a later synonym of Enterococcus italicus Fortina et al. 2004. Int. J. Syst. Evol. Microbiol.
56: 413-416
[Abstract]
[Full Text]
-
Miller, M. B., Allen, S. L., Mangum, M. E., Doutova, A., Gilligan, P. H.
(2004). Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures. J. Clin. Microbiol.
42: 855-857
[Abstract]
[Full Text]
-
Bustamante, W., Alpizar, A., Hernandez, S., Pacheco, A., Vargas, N., Herrera, M. L., Vargas, A., Caballero, M., Garcia, F.
(2003). Predominance of vanA Genotype among Vancomycin-Resistant Enterococcus Isolates from Poultry and Swine in Costa Rica. Appl. Environ. Microbiol.
69: 7414-7419
[Abstract]
[Full Text]
-
Dutta, I., Reynolds, P. E.
(2003). The vanC-3 vancomycin resistance gene cluster of Enterococcus flavescens CCM 439. J Antimicrob Chemother
51: 703-706
[Abstract]
[Full Text]
-
Van Horn, K., Toth, C., Kariyama, R., Mitsuhata, R., Kumon, H.
(2002). Evaluation of 15 Motility Media and a Direct Microscopic Method for Detection of Motility in Enterococci. J. Clin. Microbiol.
40: 2476-2479
[Abstract]
[Full Text]
-
Novais, C., Vital, C., Ribeiro, G., Coque, T. M., Peixe, L. V.
(2002). First characterization of vancomycin-resistant enterococci from a Portuguese hospital.. J Antimicrob Chemother
49: 215-217
[Full Text]
-
Angeletti, S., Lorino, G., Gherardi, G., Battistoni, F., De Cesaris, M., Dicuonzo, G.
(2001). Routine Molecular Identification of Enterococci by Gene-Specific PCR and 16S Ribosomal DNA Sequencing. J. Clin. Microbiol.
39: 794-797
[Abstract]
[Full Text]
-
Cetinkaya, Y., Falk, P., Mayhall, C. G.
(2000). Vancomycin-Resistant Enterococci. Clin. Microbiol. Rev.
13: 686-707
[Abstract]
[Full Text]
-
Kobayashi, K., Rao, M., Keis, S., Rainey, F. A., Smith, J. M. B., Cook, G. M.
(2000). Enterococci with reduced susceptibility to vancomycin in New Zealand. J Antimicrob Chemother
46: 405-410
[Abstract]
[Full Text]
-
Iwen, P. C., Rupp, M. E., Schreckenberger, P. C., Hinrichs, S. H.
(1999). Evaluation of the Revised MicroScan Dried Overnight Gram-Positive Identification Panel To Identify Enterococcus Species. J. Clin. Microbiol.
37: 3756-3758
[Abstract]
[Full Text]